Biotech

All Articles

Lilly messages much more positive data on its weekly blood insulin prospect

.On the heels of an FDA rejection for its primary rival Novo Nordisk, Eli Lilly is pushing on in the...

IN 8bio stops phase 2 test, lays off fifty percent of staff

.Simply a few months after dosing the very first patient in a phase 2 test for freshly identified gl...

Lilly, Haya ink $1B biobuck obesity contract to search dark genome

.Eli Lilly's hunt for being overweight intendeds has actually led it to the darker genome. The Big P...

ArsenalBio increases $325M, pivots off of former lead resource

.Collection Biosciences is actually proceeding up. The tissue treatment firm has actually added $325...

Lilly- backed effective weight loss biotech documents IPO

.After raising $170 million back in February, metabolic disease-focused BioAge Labs has submitted to...

Aelis' cannabis use drug flunks phase 2b, steering Indivior to reconsider $100M option

.Aelis Farma's hopes of safeguarding a simple, positive decision on a $one hundred million option pa...

ProKidney standstills stage 3 trial not needed to have for tissue treatment approval

.ProKidney has ceased among a pair of stage 3 tests for its own tissue treatment for kidney illness ...

Vaxcyte rises on 'impressive' 31-valent PCV win versus Pfizer

.Vaxcyte revealed what experts named "spectacular" period 1/2 records for its own 31-valent pneumoco...

Recursion's human brain illness test presents scant documentation of effectiveness

.Recursion has discovered via an early examination of its tech-enabled strategy to drug exploration,...

Acepodia, Pfizer click together for chemistry-based tissue therapy

.Contact it an instance of excellent chemistry: Acepodia, a biotech based on Nobel Prize-winning sci...